1999
DOI: 10.1038/sj.jhh.1000939
|View full text |Cite
|
Sign up to set email alerts
|

White coat hypertension: how should it be diagnosed?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2001
2001
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…24 Depending on the definitions used, the prevalence of this condition may be as high as 10%-20%. 25 The clinical significance of white-coat hypertension continues to be debated, with cross-sectional studies providing conflicting results. 26 In summary, the careful follow-up of white-coat hypertensive patients has shown an equal rate of development of sustained hypertension as in an age-matched group.…”
Section: White-coat Hypertensionmentioning
confidence: 99%
See 1 more Smart Citation
“…24 Depending on the definitions used, the prevalence of this condition may be as high as 10%-20%. 25 The clinical significance of white-coat hypertension continues to be debated, with cross-sectional studies providing conflicting results. 26 In summary, the careful follow-up of white-coat hypertensive patients has shown an equal rate of development of sustained hypertension as in an age-matched group.…”
Section: White-coat Hypertensionmentioning
confidence: 99%
“…This pressor effect is actually somewhat generic to the medical care environment, and its detection is the most commonly cited indication for ABPM in consensus documents 24 . Depending on the definitions used, the prevalence of this condition may be as high as 10%–20% 25 …”
Section: White‐coat Hypertensionmentioning
confidence: 99%
“…In advocating the use of ambulatory measurement annually to follow people with white coat hypertension, the fiscal argument is often invoked, namely that the technique is too expensive to justify such a recommendation, and that indiscriminate use of ABPM would place an intolerable burden on health care services. Studies on the economics of ABPM are few, and the fear of inappropriate use, especially in private practice, has had a negative influence 4. However, the main riposte to the financial argument must be that if drug treatment is postponed or averted, the savings in pharmacological costs far outweigh the technologic costs of using ABPM.…”
Section: Ambulatory Blood Pressure Measurementmentioning
confidence: 99%
“…Despite many research findings demonstrating the usefulness of ABPM in issues such as white coat hypertension [1][2][3][4], alerting reaction [5][6][7][8], circadian patterns-dipping and nondipping [9][10][11][12], variability [11,12], masked hypertension [13,14], and the management of hypertension [15], less is known about the interpretation of the initial manual calibration readings (when placing the monitor on an individual) and also these same readings at study completion (when removing the monitor) [12][13][14][15][16]. These readings are often higher than in the subsequent hours of ABPM when evaluated in white coat or sustained hypertensive groups [17].…”
Section: Introductionmentioning
confidence: 99%